Inicio>>Biochemical Assay Reagents>>Adenosine 3'-phosphate 5'-phosphosulfate lithium

Adenosine 3'-phosphate 5'-phosphosulfate lithium

Catalog No.GC67265

La adenosina 3'-fosfato 5'-fosfosulfato de litio es un cosustrato utilizado para la sulfonación de glicanos. La adenosina 3'-fosfato 5'-fosfosulfato de litio se puede utilizar para ensayos de sulfotransferasa acoplada a fosfatasa específica de PAP residente de Golgi, que como sustrato donante para transferir un grupo sulfonato.

Products are for research use only. Not for human use. We do not sell to patients.

Adenosine 3'-phosphate 5'-phosphosulfate lithium Chemical Structure

Cas No.: 109434-21-1

Tamaño Precio Disponibilidad Cantidad
1mg
396,00 $
Disponible
5mg
1.445,00 $
Disponible
25mg
5.882,00 $
Disponible

Tel:(909) 407-4943 Email: sales@glpbio.com

Reseñas de cliente

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents

Adenosine 3'-phosphate 5'-phosphosulfate lithium is a co-substrate used for the sulfonation of glycans. Adenosine 3'-phosphate 5'-phosphosulfate lithium can be used for Golgi-resident PAP-specific 3'-phosphatase-coupled sulfotransferase assays, which as donor substrate to transfer a sulfonate group[1][2].

[1]. Prather B, et, al. Golgi-resident PAP-specific 3'-phosphatase-coupled sulfotransferase assays. Anal Biochem. 2012 Apr 1;423(1):86-92.
[2]. Ryan P. Modified indole alkaloids for therapeutic uses. WO2022133314.

Reseñas

Review for Adenosine 3'-phosphate 5'-phosphosulfate lithium

Average Rating: 5 ★★★★★ (Based on Reviews and 30 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Adenosine 3'-phosphate 5'-phosphosulfate lithium

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.